Glanders

BIODEFENSE: Research Methodology and Animal Models

Volumn , Issue , 2005, Pages 95-106

  Fritz, David L ^a   Waag, David M ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84883741778     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9781420038118-11     Document Type: Chapter

References (59)

1. Miller, W. R., et al., Studies on certain biological characteristics of Malleomyces mallei and Malleomyces pseudomallei. II. Virulence and infectivity for animals, J Bacteriol 55, 127-135, 1948.
2. Howe, C., Glanders, in The Oxford Medicine, Christian, H. A., Ed., Oxford University Press, New York, 1949, pp. 185-201.
3. Pitt, L. L., Pseudomonas, in Topley and Wilson’s Principles of Bacteriology, Virology and Immunity, 8th ed., Parker, M. T. and Collier, L., Eds., H. B.C. Decker, Philadelphia, 1990, 255-273.
4. Sanford, J. P., Pseudomonas species (including melioidosis and glanders), in Principles and Practice of Infectious diseases, 3rd ed., Mandell, G. L., Douglas, J. R., and Bennett, J. E., Eds., Churchill Livingstone, New York, 1990, 1692-1696.
5. Kovalev, G. K., [Glanders (review)], Zh Mikrobiol Epidemiol Immunobiol 48(1), 63-70, 1971.
6. Benenson, A. S., Control of Communicable Diseases Manual, 16th ed., American Public Health Association, Washington, DC, 1995.
7. Steele, J. H., Glanders, in CRC Handbook Series in Zoonoses, Steele, J. H., Ed., CRC Press, Boca Raton, FL, 1979, pp. 339-351.
8. Benenson, A. S., Glanders, in Control of Communicable Diseases in Man, 15th ed., American Public Health Association, Washington, DC, 1990, pp. 77.
9. Freeman, B. A., Pseudomonas and Legionella, in Burrow’s Textbook of Microbiology, 22nd ed., W.B. Saunders, Philadelphia, 1985, pp. 544-557.
10. Redfearn, M. S. and Palleroni, N. J., Glanders and melioidosis, in Diseases Transmitted from Animals to Man, 6th ed., Hubbert, W. T., McCulloch, W. F., and Schnurrenberger, P. R., Eds., Charles C. Thomas, Springfield, IL, 1975, pp. 110-128.
11. Howe, C., Sampath, A., and Spotnitz, M., The pseudomallei group: a review, J Infect Dis 124(6), 598-606, 1971.
12. Wilkinson, L., Glanders: medicine and veterinary medicine in common pursuit of a contagious disease, Med Hist 25(4), 363-84, 1981.
13. Hornick, R. B., Diseases due to Pseudomonas mallei and Pseudomonas pseudomallei, in Infections in Children, Wedgewood, R. J., Ed., Harper and Row, Philadelphia, 1982, 910-913.
14. Steele, J. H., The zoonoses: an epidemiologist’s viewpoint, in Progress in Clinical Pathology, Stefanini, M., Grune and Stratton, Eds., New York, 1973, 239-286.
15. Gillespie, J. H. and Timoney, J. F., The genus Pseudomonas, in Hagan and Bruner’s Microbiology and Infectious Diseases of Domestic Animals Cornell University Press, Ithaca, NY, 1981, 51-60.
16. Miller, W. R., Pannell, L., and Ingalls, M. S., Experimental chemotherapy in glanders and melioidosis, Am J Hyg 47, 205-213, 1948.
17. Parker, M. T., Glanders and melioidosis, in Topley and Wilson’s Principles of Bacteriology, Virology and Immunity, 8th ed., Parker, M. T. and Collier, L. H., Eds., B.C. Decker, Philadelphia, 1990, 392-394.
18. Dungworth, D. L., The respiratory system, in Pathology of Domestic Animals, K. V. F. Jubb, P. C. Kennedy, and N. Palmer, Eds., Academic Press, Inc., New York, 1993, 553-555.
19. Vyshelesskii, S. N., Glanders (Equina), Trudy Vsesoiuznyi Inst Eksperimentalʼnoi Vet 42, 67-92, 1974.
20. Smith, G. R., Pearson, A. D., and Parker, M. T., Pasteurella infections, tularemia, glanders and melioidosis, in Topley and Wilson’s Principles of Bacteriology, Virology and Immunity, 8th ed., Smith, G. R. and Easmon, C. S., Eds., B.C. Decker, Philadelphia, 1990, 392-394.
21. Von Graevenitz, A., Clinical microbiology of unusual Pseudomonas species, Prog Clin Path 5, 185-218, 1973.
22. Sanford, J. P., Pseudomonas infection: glanders and melioidosis, in Tropical Medicine, 7th ed., Strickland, G. T., Ed., W. B. Saunders, Philadelphia, 1991, 450.
23. Popov, S. F., Kurilov, V., and Iakovlev, A. T., [Pseudomonas pseudomallei and Pseudomonas mallei are capsule-forming bacteria], Zh Mikrobiol Epidemiol Immunobiol 5, 32-36, 1995.
24. Fritz, D. L., Vogel, P., Brown, D. R., Deshazer, D., and Waag, D. M., Mouse model of sublethal and lethal intraperitoneal glanders (Burkholderia mallei), Vet Pathol 37, 626-636, 2000.
25. Bartlett, J. G., Glanders, in Infectious Diseases, Gorbach, S. L., Bartlett, J. G., and Blacklow, N. R., Eds., W.B. Saunders, Philadelphia, 1982, pp. 1293-1295.
26. Fritz, D. L., et al., The hamster model of intraperitoneal Burkholderia mallei (glanders), Vet Pathol 36(4), 276-291, 1999.
27. Smith, D. T., Conant, N. F., and Willett, H. P., Actinobacillus mallei and glanders; melioidosis and actinobacillosis, in Zinsser Microbiology, 14th ed. Appleton-Century Crofts, New York, 1968, 744-750.
28. Manzenyuk, I. N., et al., Some indices of infectious process in therapy of malleus in monkeys, Antibiot Khimioter 41(1), 13-18, 1996.
29. Manzenyuk, I. N., et al., Homeostatic changes in monkeys in a model of glanders, Antibiot Khimioter 42, 29-34, 1997.
30. Khomiakov, N., et al., The principles of the therapy of glanders in monkeys, Zh Mikrobiol Epidemiol Immunobiol 1, 70-74, 1998.
31. Dyadishchev, N. R., Vorobyev, A. A., and Zakharov, S. B., Pathomorphology and pathogenesis of glanders in laboratory animals, Zh Mikrobiol Epidemiol Immunobiol 2, 60-64, 1997.
32. Russell, P., et al., Comparison of efficacy of ciprofloxacin and doxycycline against experimental melioidosis and glanders, J Antimicrobial Chemother 45, 813-818, 2000.
33. Alekseev, V. V., et al., [The early laboratory diagnosis of the pulmonary form of glanders and melioidosis by using rapid methods of immunochemical analysis], Zh Mikrobiol Epidemiol Immunobiol 5, 59-63, 1994.
34. Manzenyuk, I. N., et al., Burkholderia mallei and Burkholderia pseudomallei. Study of immuno-and pathogenesis of glanders and melioidosis. Heterologous vaccines, Antibiot Khimioter 44, 21-26, 1999.
35. Lever, M. S., et al., Experimental aerogenic Burkholderia mallei (glanders) infection in the BALB/c mouse, J Med Microbiol 52, 1109-1115, 2003.
36. Sonnenwirth, A. C., Pseudomonads and other nonfermenting bacilli, in Microbiology, 3rd ed., Davis, B. D., Dulbecco, R., Eisen, H. N., and Ginsburg, H. S., Eds., Harper and Row Publishers, Hagerstown, MD, 1980, 674-677.
37. Duval, C. W. and White, P. G., The histological lesions of experimental glanders, J Exp Med 9, 352-380, 1907.
38. Ferster, L. N. and Kurilov, V. Y., [Characteristics of the infectious process in animals susceptible and resistant to glanders], Arkh Patol 44(11), 24-30, 1982.
39. M’Fadyean, J., Glanders, J Comp Pathol 17, 295-317, 1904.
40. Coleman, W. and Ewing, J., A case of septicemic glanders in the human subject, J Med Res 4, 223-240, 1903.
41. Galati, P., Puccini, V., and Contento, F., An outbreak of glanders in lions. Histopathological findings, Acta Med Vet 19, 261-277, 1973.
42. Mohler, J. R. and Eichhorn, A., Immunization tests with glanders vaccine, J. Comp. Path. 27, 183-185, 1914.
43. Amemiya, K., et al., Nonviable Burkholderia mallei induces a mixed Th1-and Th2-like cytokine response in BALB/c mice, Infect Immun 70, 2319-2325, 2002.
44. Hagebock, J. M., et al., Serologic responses to the mallein test for glanders in solipeds, J Vet Diagn Invest 5(1), 97-9, 1993.
45. Gangulee, P. C., Sen, G. P., and Sharma, G. L., Serological diagnosis of glanders by haemagglutination test, Indian Vet J 43(5), 386-91, 1966.
46. Sen, G. P., Singh, G., and Joshi, T. P., Comparative efficacy of serological tests in the diagnosis of glanders, Indian Vet J 45(4), 286-92, 1968.
47. Sanford, J. P., Melioidosis and glanders, in Harrison’s Principles of Internal Medicine, 12th ed., Wilson, E. B. J. D. and Isselbacher, K. J., Eds., McGraw-Hill, New York, 1991, 606-609.
48. Heine, H. S., et al., In vitro antibiotic susceptibilities of Burkholderia mallei (causative agent of glanders) determined by broth microdilution and E-test, Antimicrob Agents Chemother 45, 2119-2121, 2001.
49. Kenny, D. P., et al., In vitro susceptibilities of Burkholderia mallei in comparison to those of other pathogenic Burkholderia spp, Antimicrob Agents Chemother 43, 2773-2775, 1999.
50. Tribuddharat, C., et al., Burkholderia pseudomallei class a beta-lactamase mutations that confer selective resistance against ceftazidime or clavulanic acid inhibition, Antimicrob Agents Chemother 47, 2082-2087, 2003.
51. Batmanov, V. P., [Sensitivity of Pseudomonas mallei to fluoroquinolones and their efficacy in experimental glanders], Antibiot Khimioter 36(9), 31-34, 1991.
52. Batmanov, V. P., [Sensitivity of Pseudomonas mallei to tetracyclines and their effectiveness in experimental glanders], Antibiot Khimioter 39(5), 33-7, 1994.
53. Iliukhin, V. I., et al., [Effectiveness of treatment of experimental glanders after aerogenic infection], Antibiot Khimioter 39 (9-10), 45-8, 1994.
54. Manzenyuk, I. N., Dorokhin, V. V., and Svetoch, E. A., [The efficacy of antibacterial preparations against Pseudomonas mallei in in vitro and in vivo experiments], Antibiot Khimioter 39, 26-30, 1994.
55. Manzenyuk, I. N., et al., [Resistance of Pseudomonas malei to tetracyclines: assessment of the feasibility of chemotherapy], Antibiot Khimioter 40, 40-44, 1995.
56. Howe, C. and Miller, W. R., Human glanders: report of six cases, Ann Intern Med 26, 93-115, 1947.
57. Srinivasan, A., et al., Glanders in a military research microbiologist, N Engl J Med 345(4), 256-258, 2001.
58. Womack, C. R. and Wells, E. B., Co-existent chronic glanders and multiple cystic osseous tuberculosis treated with streptomycin, Am J Med 6, 267-271, 1949.
59. Anasbi, M. and Minou, M., Two cases of chronic human glanders treated with sulfamides (in French), Ann Inst Pasteur 81, 98-102, 1951.